Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07553234 · ClinicalTrials.gov registry record · NA
Study to Understand Relationship Between Gut Health and Toxicities of Hormonal Breast Cancer Treatment
A NA study, sponsored by University of Chicago.
- Not yet
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT07553234: Clinical Trial NA study, sponsored by University of Chicago.
NCT07553234 is a NA study that has not yet begun recruiting, run by University of Chicago. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07553234, a NA study, has not yet begun recruiting, sponsored by University of Chicago.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
This study will be conducted in 2 sequential parts. The first part will be a prospective, observational study. This will be followed by a small interventional, pilot study involving use of fiber supplement (chia seeds). The study aims to evaluate the relationship between the gut microbiome (a diverse ecosystem of microorganisms that affects your health and well-being) and treatment-related gastrointestinal toxicities in patients with HR+/HER2- breast cancer receiving abemaciclib plus endocrine therapy.
Primary Outcome
Proportion of enrolled participants who provide serial stool samples during the baseline and on-treatment periods, as recorded by device data and study records.
Interventions
- OTHER Chia Seeds
- OTHER Stool Sampling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2026-12-27 |
| Est. Completion | 2030-05-03 |
| Phase | NA |
What is known before NCT07553234 opens enrollment
NCT07553234 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Chia Seeds is the first listed.
NCT07553234 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07553234 about?
NCT07553234 is a clinical study titled "Study to Understand Relationship Between Gut Health and Toxicities of Hormonal Breast Cancer Treatment". This study will be conducted in 2 sequential parts. The first part will be a prospective, observational study. This will be followed by a small interventional, pilot study involving use of fiber supplement (chia seeds). The study aims to evaluate the relationship between the gut microbiome (a divers...
What is the current status of trial NCT07553234?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2026-12-27. Estimated completion is 2030-05-03.
What interventions are being tested in trial NCT07553234?
The interventions under investigation include: Chia Seeds (OTHER), Stool Sampling (OTHER).
Who is sponsoring clinical trial NCT07553234?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07553234's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI